SUMMARY
- Tesorai raised $5.3 million in Seed funding.
- It will use the funds to grow its platform.
- Tesorai builds AI tools to analyse biological data.
Tesorai, a San Diego, CA-based provider of a searchable knowledge layer platform for life sciences, has raised $5.3 million in a Seed funding round, bringing the total to $8 million.
The round saw backers including Perplexity Fund, IQT, South Central Ventures, New Stack Ventures, NextGen Venture Partners, f7 Ventures, VitalStage Ventures, and ZAKA.
The company will use the funding to expand its work with biopharmaceutical companies and research customers, build partnerships across the life sciences tools industry and extend its platform beyond proteins to other types of molecular data.
What is Tesorai?
Tesorai develops AI-powered tools that help scientists search, analyse and use biological data from experiments.
Read More:BrightAI Raises $97M in Funding Led by Smith Point Capital
Millions of scientific experiments have produced large amounts of data stored across public repositories, research institutions and company databases. However, much of this information is difficult to access and compare because it has been processed using different methods and often lacks consistent descriptions.
Tesorai's platform goes back to the original experimental data, processes it and organises the information so researchers can search and compare findings across studies.
Its platform includes three main products:
- Tesorai Search: Processes raw scientific data, including mass spectrometry files, and makes the results searchable.
- Tesorai Chat: Allows researchers to run data analyses using conversational prompts.
- Tesorai Trove: Provides a collection of structured public proteomics datasets that researchers can use to validate and compare findings.
The platform is used by biopharmaceutical companies and research institutions for drug discovery, biomarker validation, and product characterisation. It's structured data can also help improve AI models used in biological research.
RECOMMENDED FOR YOU
[Funding alert] CA-based Radionetics Oncology Secures $52.5M in Series A Round Funding
Devin Jacobs
Jan 4, 2024
How Much Funding Has Tesorai Raised?
Tesorai has raised $5.3 million in its latest Seed funding round, bringing its total funding to $8 million.
The company has not disclosed details of its previous funding rounds.
Who Invested in Tesorai’s Seed Round?
The $5.3 million Seed round included participation from:
- Perplexity Fund
- IQT
- South Central Ventures
- New Stack Ventures
- NextGen Venture Partners
- f7 Ventures
- VitalStage Ventures
- ZAKA
The company did not identify a lead investor for the round.
Why the Funding Matters
Tesorai plans to use the funding to expand its work with biopharmaceutical companies, and research institutions.
It will also build partnerships across the life sciences tools industry, and extend its platform beyond proteins to support other types of molecular data.
The investment will help the company make more experimental data accessible to scientists and AI developers, supporting research, and the development of AI models of biology.
Who founded Tesorai?
Tesorai was founded by Melissa Miao, Peter Cimermancic and Charlie Kim.
The company is headquartered in San Diego, California. It develops AI tools designed to help scientists extract more useful information from molecular data.
"Life science R&D is accelerating and becoming increasingly autonomous, which makes it more important to extract as much insight as possible from every experiment," said Charlie Kim, co-founder and chief scientific officer of Tesorai. "Tesorai does this for a lab's new data and for thousands of published studies. The gains compound as each experiment builds on the last, and ultimately, this helps the industry develop better medicines and products, faster."
Market and Business Growth
Tesorai's platform has processed thousands of files, and terabytes of scientific data. The company says its patented model can process this information in a few hours, a task that previously took months using older methods.
It's Tesorai Trove platform includes thousands of curated and structured public proteomics datasets. The companys research has also explored how protein data can improve AI models of biology.
In an August preprint, Tesorai researchers reported that adding protein data helped a smaller single cell AI model match or outperform larger models trained only on RNA data across multiple benchmarks.
Tesorai's work comes as research organisations and technology companies invest in generating and organising biological data for AI applications.
What Happens Next?
Tesorai plans to expand its partnerships with biopharmaceutical companies and research organisations while adding more types of molecular data to its platform.
The company will continue developing its search and analysis tools to help researchers access existing experimental data, compare findings and support the development of AI models for biological research.
Read more:Galvanize Therapeutics Secures $130M in Series D Financing
Recommended Stories for You
[Funding alert] Ladder Secures $12 Mn in Series A Round led by Tapestry VC and LivWell Ventures
Devin Jacobs Dec 7, 2023







